Methylphenidate Hydrochloride Immediate Release Tablets
Last Updated: April 8, 2015
Status: Current
Products Affected - Description
Methylphenidate, Mallinckrodt
5 mg tablets, 1000 count (NDC 00406-1142-10) - discontinued
10 mg tablets, 1000 count (NDC 00406-1144-10) - discontinued
20 mg tablets, 1000 count (NDC 00406-1146-10) - discontinued
Reason for the Shortage
- Mallinckrodt states the shortage was due to delay in obtaining raw materials. The company has stopped using the trade name Methylin and all products are now marketed as methylphenidate immediate-release or extended-release tablets with new NDC numbers.
- Sandoz states that the shortage was due to delay in obtaining raw materials.
- UCB states methylphenidate IR tablets were on shortage due to supply and demand.
- Actavis states the shortage of methylphenidate was due to increased demand.
Available Products
Methylphenidate, Actavis
5 mg tablets, 100 count (NDC 00591-5882-01)
20 mg tablets, 100 count (NDC 00591-5884-01)
5 mg tablets, 100 count (NDC 57664-0228-88)
10 mg tablets, 100 count (NDC 57664-0229-88)
20 mg tablets, 100 count (NDC 57664-0230-88)
Methylphenidate, Core Pharma
5 mg tablets, 100 count (NDC 64720-0237-10)
10 mg tablets, 100 count (NDC 64720-0238-10)
20 mg tablets, 100 count (NDC 64720-0239-10)
Methylphenidate, Mallinckrodt
5 mg tablets, 100 count (NDC 00406-1142-01)
10 mg tablets, 100 count (NDC 00406-1144-01)
20 mg tablets, 100 count (NDC 00406-1146-01)
Methylphenidate, Sandoz
5 mg tablets, 100 count (NDC 00781-5748-01)
20 mg tablets, 100 count (NDC 00781-5753-01)
5 mg tablets, 100 count (NDC 53014-0531-07)
10 mg tablets, 100 count (NDC 53014-0530-07)
20 mg tablets, 100 count (NDC 53014-0532-07
Ritalin, Novartis
5 mg tablets, 100 count (NDC 00078-0439-05)
10 mg tablets, 100 count (NDC 00078-0440-05)
Estimated Resupply Dates
All presentations are available.
Related Shortages
- Acetaminophen and Codeine Phosphate 300 mg/30 mg Tablets — Resolved
- Cefepime Injection — Current
- Dexmethylphenidate Hydrochloride — Resolved
- Flumazenil Injection — Current
- Levorphanol Tablets — Resolved
- Methylphenidate Hydrochloride Chewable Tablets — Current
- Methylphenidate Hydrochloride Extended Release Oral Presentations — Resolved
- Methylphenidate Transdermal — Current
- Pramipexole Dihydrochloride Tablets — Resolved
- Reserpine Oral Tablets — No Longer Available — No Commercially Available Preparations
- Rotigotine Transdermal Systems (Neupro) — Resolved
Updated
May 4, April 8, March 9, February 4 and 23, January 9 and 23, 2015; December 3, 10, and 18, November 5, October 10, September 10 and 24, August 15, June 5 and 23, April 15, March 27, February 11 and 27, January 17, 2014; November 14, October 17, September 12,16, and 23, August 13 and 28, July 3, 11, and 29; June 7 and 20, May 15 and 22, April 5, March 5 and 8, February 22, January 24, 2013; November 2 and 30, October 1, September 12, July 18, June 25, May 17, April 23, March 8, February 17, January 13 and 30, 2012; December 1 and 14, October 6 and 19, September 21, August 3, July 6, June 6 and 23, May 5, 13, and 19, April 8, March 8 and 23, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
